Home > Insider Trading > Filing (0001209191-21-018051)

Filing Details

Accession Number:: 0001209191-21-018051
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2021-03-05 06:08:48
Reporting Period:: 2021-03-01

Accepted Time:: 2021-03-05 06:08:48
Original Submission Date:: 2021-03-03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1322505	Albireo Pharma Inc.	ALBO	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1687436	Jan Mattsson	C/O Albireo Pharma Inc. 10 Post Office Square, Suite 1000 Boston MA 02109	Chief Scientific Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2021-03-01	39,330	$1.00	69,044	No	4	M	Direct
Common Stock	Disposition	2021-03-01	15,300	$37.45	53,744	No	4	S	Direct
Common Stock	Disposition	2021-03-02	12,351	$36.07	41,393	No	4	S	Direct
Common Stock	Disposition	2021-03-02	612	$36.54	40,781	No	4	S	Direct
Common Stock	Disposition	2021-03-02	2,807	$37.15	37,974	No	4	S	Direct
Common Stock	Disposition	2021-03-03	400	$36.20	37,574	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2021-03-01	39,330	$0.00	39,330	$1.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2021-03-18	No	4	M	Direct

Footnotes

Represents 63,544 shares of common stock and 5,500 restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.10 to $37.81, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 48,244 shares of common stock and 5,500 restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 35,893 shares of common stock and 5,500 restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.52 to $36.62, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 35,281 shares of common stock and 5,500 restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.00 to $37.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 32,474 shares of common stock and 5,500 restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.27, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
Represents 32,074 shares of common stock and 5,500 restricted stock units.
This option is fully vested.